COMPANY

OyaGen, Inc.

HQ: Rochester, NY source · oyageninc.com ↗ · Mid-Atlantic

Keywords: infectious disease acquired immunodeficiency syndrome

Location: Rochester, NY · source · Oct 14, 2026

Profile checked Oct 10, 2026

21NIH grants

NIH awards 21

Annual award amounts. Total $6.8M.

Jul 15, 2024 NIH award 5R43AI179320-02 FY2024: $298,000 awarded for that fiscal year; activity R43 (SBIR); PI BENNETT, RYAN P; recipient as written: OYAGEN, INC., ROCHESTER, NY. High throughput screening and drug discovery for an source ↗
Mar 13, 2024 NIH award 5R43AI167113-02 FY2024: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI BENNETT, RYAN P; recipient as written: OYAGEN, INC., ROCHESTER, NY. IND-Enabling Development of a Small Molecule COVID source ↗
Aug 10, 2023 NIH award 1R43AI179320-01 FY2023: $299,000 awarded for that fiscal year; activity R43 (SBIR); PI SALTER, JASON DOUGLAS; recipient as written: OYAGEN, INC., ROCHESTER, NY. High throughput screening and drug discovery source ↗
Mar 21, 2023 NIH award 1R43AI167113-01A1 FY2023: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI BENNETT, RYAN P; recipient as written: OYAGEN, INC., ROCHESTER, NY. IND-Enabling Development of a Small Molecule COVI source ↗
Jul 1, 2021 NIH award 5R43AI155113-02 FY2021: $286,431 awarded for that fiscal year; activity R43 (SBIR); PI SALTER, JASON DOUGLAS; recipient as written: OYAGEN, INC., ROCHESTER, NY. Development of Lead Inhibitors of HIV Vif Bin source ↗
Jun 12, 2020 NIH award 1R43AI155113-01 FY2020: $286,431 awarded for that fiscal year; activity R43 (SBIR); PI SALTER, JASON DOUGLAS; recipient as written: OYAGEN, INC., ROCHESTER, NY. Development of Lead Inhibitors of HIV Vif Bin source ↗
Jul 5, 2019 NIH award 5R43AI134172-02 FY2019: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI BENNETT, RYAN P; recipient as written: OYAGEN, INC., ROCHESTER, NY. Preclinical Development of HIV Vif Antagonists source ↗
Aug 3, 2018 NIH award 1R43AI134172-01A1 FY2018: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI BENNETT, RYAN P; recipient as written: OYAGEN, INC., ROCHESTER, NY. Preclinical Development of HIV Vif Antagonists source ↗
Jul 25, 2017 NIH award 5R21AI122845-02 FY2017: $200,879 awarded for that fiscal year; activity R21 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Binding Interface of HIV Vif and APOBEC3G as a source ↗
Jan 5, 2017 NIH award 5R01GM110119-03 FY2017: $560,451 awarded for that fiscal year; activity R01 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Discovery of Chemical Probes for RNA-Binding P source ↗
Aug 5, 2016 NIH award 1R21AI122845-01A1 FY2016: $403,638 awarded for that fiscal year; activity R21 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Binding Interface of HIV Vif and APOBEC3G as source ↗
Jan 14, 2016 NIH award 5R01GM110119-02 FY2016: $605,606 awarded for that fiscal year; activity R01 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Discovery of Chemical Probes for RNA-Binding P source ↗
Aug 17, 2015 NIH award 5R01GM110568-03 FY2015: $439,233 awarded for that fiscal year; activity R01 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Identification of Antagonists of the Molecular source ↗
Apr 10, 2015 NIH award 1R01GM110119-01A1 FY2015: $601,514 awarded for that fiscal year; activity R01 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Discovery of Chemical Probes for RNA-Binding source ↗
Sep 19, 2014 NIH award 3R01GM110568-02S1 FY2014: $44,845 awarded for that fiscal year; activity R01 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Identification of Antagonists of the Molecula source ↗
Jul 23, 2014 NIH award 5R01GM110568-02 FY2014: $439,233 awarded for that fiscal year; activity R01 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Identification of Antagonists of the Molecular source ↗
Sep 24, 2013 NIH award 1R01GM110568-01 FY2013: $468,483 awarded for that fiscal year; activity R01 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Identification of Antagonists of the Molecular source ↗
May 16, 2012 NIH award 5R21AI095007-02 FY2012: $210,000 awarded for that fiscal year; activity R21 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Development of a Novel HIV/AIDS Therapeutic Ac source ↗
May 9, 2011 NIH award 1R21AI095007-01A1 FY2011: $252,000 awarded for that fiscal year; activity R21 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Development of a Novel HIV/AIDS Therapeutic source ↗
Dec 6, 2010 NIH award 3R21NS067671-01S1 FY2011: $32,250 awarded for that fiscal year; activity R21 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Development of a High Throughput Screen for A source ↗
Sep 25, 2009 NIH award 1R21NS067671-01 FY2009: $128,710 awarded for that fiscal year; activity R21 (OTHER_NIH); PI SMITH, HAROLD C; recipient as written: OYAGEN, INC., ROCHESTER, NY. Development of a High Throughput Screen for An source ↗